ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,045.43
-0.03%
Dow Jones
44,726.98
-0.12%
US Dollar vs MXN
20.33735
-0.37%
Brent Oil
73.525
2.27%
Bitcoin
95,527.19
-0.35%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Noticias

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:AZN
FechaHoraFuenteTítuloSímboloCompañía
02/12/202409:05RNS Regulatory NewsAstraZeneca PLC Block listing Interim ReviewLSE:AZNAstrazeneca Plc
02/12/202409:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
25/11/202402:51Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails positive Truqap data on prostate cancerLSE:AZNAstrazeneca Plc
25/11/202401:00RNS Regulatory NewsAstraZeneca PLC Truqap improved rPFS in advanced prostate cancerLSE:AZNAstrazeneca Plc
20/11/202410:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
19/11/202409:47Alliance NewsAlliance NewsAstraZeneca "disappointed" as breast cancer drug blocked for NHS useLSE:AZNAstrazeneca Plc
18/11/202406:43Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buyLSE:AZNAstrazeneca Plc
18/11/202403:01Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails recommended EU approval of TagrissoLSE:AZNAstrazeneca Plc
18/11/202401:00RNS Regulatory NewsAstraZeneca PLC Tagrisso recommended for EU approval - LAURALSE:AZNAstrazeneca Plc
15/11/202405:04Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in sharesLSE:AZNAstrazeneca Plc
12/11/202413:50Alliance NewsAlliance NewsIN BRIEF: Merck trial shows Koselugo effective in treating adultsLSE:AZNAstrazeneca Plc
12/11/202406:21Alliance NewsAlliance NewsEXTRA: AstraZeneca results impress but China a likely short-term dragLSE:AZNAstrazeneca Plc
12/11/202402:59Alliance NewsAlliance NewsTOP NEWS: AstraZeneca lifts annual guidance despite possible forex hitLSE:AZNAstrazeneca Plc
12/11/202401:10RNS Regulatory NewsAstraZeneca PLC AstraZeneca invests $3.5 billion in USLSE:AZNAstrazeneca Plc
12/11/202401:05RNS Regulatory NewsAstraZeneca PLC KOMET Phase III trial met primary endpointLSE:AZNAstrazeneca Plc
12/11/202401:00RNS Regulatory NewsAstraZeneca PLC 9M and Q3 2024 ResultsLSE:AZNAstrazeneca Plc
12/11/202401:00RNS Regulatory NewsAstraZeneca PLC Dato-DXd new BLA submitted, NSQ BLA withdrawnLSE:AZNAstrazeneca Plc
08/11/202403:13Alliance NewsAlliance NewsAstraZeneca touts positive results from nasal polyp treatment studyLSE:AZNAstrazeneca Plc
08/11/202401:00RNS Regulatory NewsAstraZeneca PLC Tezspire nasal polyps trial met primary endpointsLSE:AZNAstrazeneca Plc
07/11/202405:14Alliance NewsAlliance NewsTOP NEWS: AstraZeneca says China chief detained as under investigationLSE:AZNAstrazeneca Plc
05/11/202412:39Alliance NewsAlliance NewsTOP NEWS: AstraZeneca pledges to assist in China probe as shares slideLSE:AZNAstrazeneca Plc
05/11/202410:49RNS Regulatory NewsAstraZeneca PLC AZN share price movementLSE:AZNAstrazeneca Plc
30/10/202409:30Alliance NewsAlliance NewsIN BRIEF: AstraZeneca China President Leon Wang under investigationLSE:AZNAstrazeneca Plc
28/10/202403:46Alliance NewsAlliance NewsAstraZeneca pleased as EU approves Fasenra for treatment of EGPALSE:AZNAstrazeneca Plc
21/10/202402:35Alliance NewsAlliance NewsAstraZeneca polyneuropathy treatment recommended for EU approvalLSE:AZNAstrazeneca Plc
21/10/202401:00RNS Regulatory NewsAstraZeneca PLC Wainzua recommended for approval in the EULSE:AZNAstrazeneca Plc
16/10/202403:52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising resultsLSE:AZNAstrazeneca Plc
14/10/202404:42Alliance NewsAlliance NewsTOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in ChinaLSE:AZNAstrazeneca Plc
07/10/202404:20Alliance NewsAlliance NewsAstraZeneca enters agreement to strengthen cardiovascular pipelineLSE:AZNAstrazeneca Plc
07/10/202403:30RNS Regulatory NewsAstraZeneca PLC AstraZeneca licenses lipid lowering Lp(a) assetLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Su Consulta Reciente

COIN
DOGEUSD
Dogecoin
FX
EURMXN
Euro vs MXN
AMEX
XLE
Energy Select Sector SPDR
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
CCOM
OILBRENT
Brent Oil
NYSE
DIS
Walt Disney
FX
USDMXN
US Dollar vs MXN
NYSE
AXP
American Express
NYSE
KO
Coca Cola
CCOM
SILVER
SILVER
USI
USTECH100
US Tech 100
COIN
XRPUSD
Ripple
NYSE
CVX
Chevron
NASDAQ
TSLA
Tesla
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados